Q2 2026 earnings call recap: 17% core revenue growth, 18% margin, raised FY26 guidance, AI fraud wins, and Q3 outlook—read key takeaways.

December CPI data shows overall inflation pressures continue to cool, with headline inflation steady at 2.7% YoY and core at 2.6% YoY. Core goods inflation softened, offsetting firm ...

Rejuvant’s CaAKG Supplement Becomes Core Requirement in Lionheart’s KLOTHO-UP™ Study and Klotho Wellness Program ...

Ditch the exhausting marathons and reclaim your midsection with a professional-grade circuit designed to activate deep ...

BILL Holdings (BILL) shares jumped 14% in Friday morning trading after the small-business-focused financial operations ...

Dietary supplements are not approved for safety or efficacy by the U.S. Food and Drug Administration (FDA), and ingredients ...

After being pushed back from its original window, Marathon is finally nearing release, with Bungie promising changes shaped by criticism from its alpha playtest and a renewed push to refine the ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...

Cognizant’s BPO business is expected to grow for decades despite the rise of AI because of need to modernize legacy processes and operations, Kumar said.

Berlin stays in its lane with a 2026 lineup favoring arthouse core over Hollywood flash.

Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

Discover how premium massage chairs aid nervous system recovery, lower cortisol, and resolve difficulty sleeping through advanced ergonomic technology.